Department of Surgery, Washington University in St Louis, St Louis, MO, USA; Barnes-Jewish Hospital, St Louis, MO, USA.
University College Dublin School of Medicine, Ireland.
HPB (Oxford). 2022 Jul;24(7):1162-1167. doi: 10.1016/j.hpb.2021.12.008. Epub 2021 Dec 16.
Multimodal analgesia and regional anesthetic blocks, such as transversus abdominis plane (TAP) block, decrease postoperative opiate consumption but their effect on intraoperative opiates is unknown.
This was a retrospective review of patients undergoing pancreatoduodenectomy between June 2018 and February 2021, in which perioperative data, operative times, and medication administration data were collected. Intraoperative opiate use was calculated in total morphine equivalent doses (MED) for each patient and adjusted for operative time. Univariate analysis and multivariate linear regression were performed to determine factors affecting intraoperative opiate requirements.
Of the 169 patients in the study, 51 (30.2%) received pre-surgical TAP blocks and 118 (69.8%) did not. There were no statistically significant differences in intraoperative opiate use with preoperative acetaminophen (p = 0.527), celecoxib (p = 0.553), gabapentin (p = 0.308), intraoperative ketorolac (p = 0.698) or epidural placement (p = 0.086). Minimally invasive surgery had lower intraoperative opiate use compared to open (p = 0.011), as well as pre-surgical TAP block compared to no pre-surgical block (5.24 vs 7.27 MED/hour, p < 0.001). On multivariate linear regression, pre-surgical TAP block (p = 0.001) was independently associated with decreased intraoperative opiate use.
Preoperative TAP blocks were associated with decreased intraoperative opiate use during pancreatoduodenectomy and should be considered for routine use.
多模式镇痛和区域麻醉阻滞,如腹横肌平面(TAP)阻滞,可以减少术后阿片类药物的消耗,但它们对术中阿片类药物的影响尚不清楚。
这是一项回顾性研究,纳入了 2018 年 6 月至 2021 年 2 月期间接受胰十二指肠切除术的患者,收集围手术期数据、手术时间和药物管理数据。每位患者的术中阿片类药物使用量均以吗啡等效剂量(MED)计算,并根据手术时间进行调整。采用单因素分析和多元线性回归分析确定影响术中阿片类药物需求的因素。
在研究的 169 名患者中,51 名(30.2%)接受了术前 TAP 阻滞,118 名(69.8%)未接受。术前使用对乙酰氨基酚(p=0.527)、塞来昔布(p=0.553)、加巴喷丁(p=0.308)、术中使用酮咯酸(p=0.698)或硬膜外置管(p=0.086)对术中阿片类药物的使用无统计学差异。微创手术组与开放手术组相比,术中阿片类药物的使用量较低(p=0.011),术前 TAP 阻滞组与无术前 TAP 阻滞组相比,术中阿片类药物的使用量也较低(5.24 比 7.27 MED/小时,p<0.001)。多元线性回归分析显示,术前 TAP 阻滞(p=0.001)与术中阿片类药物使用减少独立相关。
术前 TAP 阻滞与胰十二指肠切除术中阿片类药物用量减少相关,应考虑常规使用。